Industry Update: Clinical Research Organizations

Industry Highlights

  • On July 2, 2021, ICON completed the previously announced acquisition of contract research company PRA Health Sciences for a total consideration of approximately $12.0 billion. The companies signed a merger agreement in February 2021, under which ICON paid $80.0 in cash per share and 0.4125 shares of its stock to PRA shareholders.
  • On June 25, 2021, PerkinElmer completed the purchase of Nexcelom Bioscience from Ampersand Capital Partners for $260 million in cash. Nexcelom is the manufacturer of Cellometer, Cellaca MX, and Celigo image cytometry products for cell analysis in drug discovery, development, and manufacturing workflows.

Past Industry Updates

Clinical Research Organizations

+ Read the May 2021 update

Clinical Research Organizations

+ Read the January 2021 update

Clinical Research Organizations

+ Read the October 2020 update

Clinical Research Organizations

+ Read the July 2020 update

Clinical Research Organizations

+ Read the May 2020 update

Clinical Research Organizations

+ Read the December 2019 update

Clinical Research Organizations

+ Read the October 2019 update

More Industry Reports